NCT06107114 2023-11-22
CZCNRHNSCC
Sun Yat-sen University
Phase 2 Unknown
Clinical Trials
11 trialsNCT06130007 2023-11-13
B2023-153
Sun Yat-sen University
Phase 2 Unknown
NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT06023875 2023-09-05
NCCCNRHNSCC
Sun Yat-sen University
Phase 2 Unknown
NCT05611463 2022-11-10
CHANCE
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Unknown
NCT05027204 2022-10-13
A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1/2 Unknown
NCT04367909 2021-11-08
A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma
China Three Gorges University, Yichang, China
Phase 2 Unknown
NCT04780750 2021-03-03
Concurent Chemoradiotherapy in Head and Neck Cancers
Assiut University
Phase 3 Unknown
NCT04766827 2021-02-23
Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Unknown
NCT02753140 2016-04-27
Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Unknown
NCT00625937 2011-02-28
Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Unknown